Pay in 4 interest-free payments of $32.73 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Oncol Lett
in a dose-response manner in the rat HOSP
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
a novel hypoglycaemic agent
Indirubin 0156 Oncol LettIndirubin is a potent and selective CDK inhibitor. Indirubin is the active ingredient of Danggui Longhui Wan, a mixture of plants that is used in traditional Chinese medicine to treat chronic diseases. Indirubin has been used to treat the symptoms of leukemia. Further biological explorations revealed the ability of indirubin to bind cyclin dependent kinases and 6 bromoindirubin, extracted from mollusks, to bind glycogen synthase kinase 3. Studies have
US$ 172.00
US$ 129.50
US$ 40.00
US$ 56.00
US$ 31.00
US$ 173.00
US$ 111.50